Experimental study of the effects of Dietressa, a new weight-reducing drug.
The capacity of a new drug containing ultra-low doses of antibodies to cannabinoid receptor type 1 (Dietressa) to reduce body weight gain in mice on a high-calorie diet was evaluated, possible mechanisms of drug action were analyzed, and its safety (abuse potential in the reaction of self-stimulation) was evaluated. Dietressa was not inferior to sibutramine in reducing body weight gain in mice and exhibited no abuse potential.
Materia Medica Holding, Moscow, Russia. email@example.com
SourceBulletin of experimental biology and medicine 152:3 2012 Jan pg 321-4
Pub Type(s)Journal Article